Cardiovascular effects of angiotensin A: A novel peptide of the renin–angiotensin system
Introduction: Angiotensin (Ang) A was first identified in human plasma and it differs from Ang II in Ala 1 instead of Asp 1 . Here, we hypothesized that the actions of this peptide might explain, at least partially, the limited effects of AT 1 R antagonists in certain cardiovascular diseases. Materi...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publications
2014-12-01
|
| Series: | Journal of the Renin-Angiotensin-Aldosterone System |
| Online Access: | https://doi.org/10.1177/1470320312474856 |
| Summary: | Introduction: Angiotensin (Ang) A was first identified in human plasma and it differs from Ang II in Ala 1 instead of Asp 1 . Here, we hypothesized that the actions of this peptide might explain, at least partially, the limited effects of AT 1 R antagonists in certain cardiovascular diseases. Materials and methods: The effects of Ang A and Ang II on blood pressure (BP) and heart function were compared. Importantly, participation of AT 1 R in these effects was evaluated. Furthermore, the effects of these two peptides on ischemia/reperfusion arrhythmias and involvement of calcium in these effects were investigated. Results: Administration of increasing doses of these peptides caused elevations in BP at comparable magnitude. AT 1 R blockade completely abolished these effects. The actions of these peptides in cardiac function were quite similar although the effects of Ang A were only partially blocked by losartan. Interestingly, Ang II elicited an increase in the duration of ischemia/reperfusion arrhythmias while Ang A had no effect on cardiac rhythm during reperfusion. In accordance, differently to Ang II, Ang A did not induce any significant effect on calcium transient during baseline and ischemic stress conditions. Conclusions: These data suggest that the existence of alternative peptides of the renin–angiotensin system (RAS) might contribute to the limited effects of angiotensin receptor blockers (ARBs) in certain pathophysiological circumstances. |
|---|---|
| ISSN: | 1470-3203 1752-8976 |